Difference between revisions of "Pharm Tech Agenda 2015.03.11"
Jump to navigation
Jump to search
| (4 intermediate revisions by the same user not shown) | |||
| Line 18: | Line 18: | ||
* Glossary & definitions (pages 8, 10, 25) | * Glossary & definitions (pages 8, 10, 25) | ||
| − | |||
* Reported medications (page 16) | * Reported medications (page 16) | ||
| − | |||
* Next steps | * Next steps | ||
| − | + | <p> </p> | |
=== Review of CPs === | === Review of CPs === | ||
* CP mtp-pre-1: link PRE --> MTP & type of referenced content | * CP mtp-pre-1: link PRE --> MTP & type of referenced content | ||
| − | + | ** [ftp://ftp.ihe.net/Pharmacy/TF_Maintenance-2015/CPs/Drafts/CP-PHARM-mtp-pre-1.doc Draft here] | |
| − | : | + | ** Goal: distinguish between reference to PRE and reference to MTP (same content) |
| + | <p> </p> | ||
| − | * CP mtp-pre-2: Reference to CDA | + | * CP mtp-pre-2: Reference to original CDA document (when in PML) |
| − | + | ** [ftp://ftp.ihe.net/Pharmacy/TF_Maintenance-2015/CPs/Drafts/CP-PHARM-mtp-pre-2.doc Draft here] | |
| − | : | + | ** Goal: when included in a PML, preserve the fact that several PREs or MTPs are coming from the same CDA document |
| + | ** Useful also for DIS and PADV? | ||
| + | <p> </p> | ||
=== Review of CMPD Profile document === | === Review of CMPD Profile document === | ||
| − | + | * [ftp://ftp.ihe.net/Pharmacy/yr6_2014-2015/Technical_Committee/Profiles/MedicationTreatmentPlan,%20MTP/IHE_Pharmacy_Suppl_CMPD_Rev1.5_TI_2015-03-10.docx Draft here] | |
| − | |||
| − | |||
| − | |||
Latest revision as of 10:19, 10 March 2015
Meeting details
Wednesday, 11 March 2015, 14:00 CET
WebEx details:
Meeting number: 959 390 393
Call-in Numbers: Global Call-in numbers
Agenda
Review of MTP Profile document
- Glossary & definitions (pages 8, 10, 25)
- Reported medications (page 16)
- Next steps
Review of CPs
- CP mtp-pre-1: link PRE --> MTP & type of referenced content
- Draft here
- Goal: distinguish between reference to PRE and reference to MTP (same content)
- CP mtp-pre-2: Reference to original CDA document (when in PML)
- Draft here
- Goal: when included in a PML, preserve the fact that several PREs or MTPs are coming from the same CDA document
- Useful also for DIS and PADV?